Regeneron Pharmaceuticals | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
AbbVie USD 4.81B 1.54B 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Astellas Pharma JPY 60.55B 178.91B 2025-03
AstraZeneca USD 3.4B 1.74B 2025-03
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Incyte USD 234.19M 172.64M 2025-03
Ionis Pharmaceuticals USD -147000000 40M 2025-03
J&J USD 13.63B 8.21B 2025-03
Kyowa Hakko Kirin JPY 11.88B 13.17B 2024-12
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Teva Pharmaceutical Industries USD 899M 1.22B 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 423.5M 27M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Regeneron Pharmaceuticals Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.